Shikari® (Q-ETA) Etanercept ELISA
ETA-FD-ENB
Enzyme immunoassay for the quantitative determination of free Etanercept (Enbrel®) in serum and plasma.
This kit has been especially developed for the quantitative determination of etanercept in serum and plasma samples between the Cmin and Cmax range of concentrations.
Etanercept Drug Bank Accession Number is DB00005
Etanercept is a protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis. Etanercept binds specifically to tumor necrosis factor (TNF) and thereby modulates biological processes that are induced or regulated by TNF.7,5 Such processes or molecules affected include the level of adhesion molecules expressed, as well as serum levels of cytokines and matrix metalloproteinases.
Measurement of biological drug trough levels and antibody to biological drug gained high importance during the course of treatment. These measurements enable dose adjustments and switch to another class of biological drug when necessary.
All SHIKARI® ELISA kits are suitable for biosimilar work.
All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.
For technical inquiry, please contact techsupport@matriksbiotek.com
| Required Volume (µl) | 10 |
| Total Time (min) | 70 |
| Sample | Serum, plasma |
| Sample Number | 96 |
| Detection Limit (ng/mL) | 100 |
| Spike Recovery (%) | Between 85-115 |
| Shelf Life (year) | 1 |
| Assay type | Quantitative |
| Species Reactivity | Human |
| Storage conditions | Store at +4°C. Please refer to protocols. |
| Shipping conditions | At room temperature |
| # | File | Action |
|---|---|---|
| Instructions For Use | Download | |
| Safety Data Sheet (SDS) | Download | |
| Validation Report | Download |
Publications with this drug
| # | File | Action |
|---|---|---|
| Iwasaki, Takeshi, et al. "Dynamics of type I and type II interferon signature determines responsiveness to anti-TNF therapy in rheumatoid arthritis." Frontiers in immunology 13 (2022): 901437. | Visit Link | |
| MOHSEN, ENAS RIYADH, and NAAEL H. ALI. "IMPACT OF TH17/TREGFOXP3 CELLS RATIO ON RHEUMATOID ARTHRITIS PATIENTS RECEIVING ANTI TNF-THERAPY-." Journal of Duhok University 24.2 (2021): 90-102. | Visit Link | |
| Lombardi, Stefania, et al. "Biologic therapies in rheumatic diseases: drug and anti-drug antibody levels and clinical efficacy." (2017). | Download | |
| Aldrich, Melissa B., et al. "Lymphatic delivery of etanercept via nanotopography improves response to collagen-induced arthritis." Arthritis research & therapy 19 (2017): 1-13. | Visit Link | |
| Gibellini, Lara, et al. "Anti-TNF-α drugs differently affect the TNFα-sTNFR system and monocyte subsets in patients with psoriasis." PLoS One 11.12 (2016): e0167757. | Visit Link | |
| Erdemli, Özge, et al. "In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes." Journal of Biomaterials Applications 29.4 (2014): 524-542. | Visit Link | |
| Jung, Young-Seok, Wooram Park, and Kun Na. "Temperature-modulated noncovalent interaction controllable complex for the long-term delivery of etanercept to treat rheumatoid arthritis." Journal of Controlled Release 171.2 (2013): 143-151. | Visit Link | |
| Chio, Chung-Ching, et al. "Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-α." BMC neuroscience 14 (2013): 1-12. | Visit Link | |
| Shin, Seung Han, et al. "TNF-α antagonist attenuates systemic lipopolysaccharide-induced brain white matter injury in neonatal rats." BMC neuroscience 20 (2019): 1-9. | Visit Link | |
| TEZCANER, Aysen, et al. "Controled Drug Delivery Systems for Anti-TNF-α." | Visit Link | |
| Efficacy of tumor necrosis factor-α inhibitors in the treatment of various immunoinflammatory diseases:focus on immunogenicity/Эффективность ингибиторов фактора некроза опухоли α в лечении различных иммуновоспалительных заболеваний:фокус на иммуногенность | Visit Link | |
| Akçadağ, Gülşah, et al. "Study on Cloning and Expression of TNF-α Variants in E. coli: Production, Purification, and Interaction with Anti-TNF-α Inhibitors." Protein and Peptide Letters 31.5 (2024): 395-408. | Visit Link |